However, knowledge on this topic is still limited, and there is a need for multi-center studies to evaluate the effects of GLP-1 receptor agonists on improving insulin signaling across different body tissues in individuals with insulin resistance. This evidence concerns the gene GLP1R and Insulin resistance.